Episode #20: The Future of Diagnostics: Technology driven personalised and preventative healthcare in Europe has been saved
Perspectives
Episode #20: The Future of Diagnostics: Technology driven personalised and preventative healthcare in Europe
Life Sciences Connect
On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts:
- Andy Flockhart, UK MedTech Leader
- Guido Baechler, CEO of Mainz Biomed
And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte
Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring.
While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base. However, innovative companies struggle to get their products to market due to a series of challenges, and as a result, diagnostics testing is taking much longer, causing backlogs in healthcare systems.
Listen to hear more on this topic.
Life Sciences Connect
To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library.
Recommendations
Life Sciences Connect
Our podcast series on the Life Sciences and Healthcare Industries
The future of diagnostics
While an appreciation of the central role that diagnostics play in European healthcare has increased substantially in recent years, diagnostics companies still face many challenges in the design, development, funding, regulation and adoption of new products.